Clinician-led perspective on aesthetics, hormones, peptides, and medical weight loss. Written for patients, not for algorithms.
Laser marketing tends to sound the same no matter what machine is in the room. Here is a plain look at what the Fotona laser is, what it can and cannot do for your skin, and how we decide if it belongs in your plan.
Melasma is the brown patching on the cheeks, lip, and forehead that comes back every summer. Here is what actually drives it, the labs we run before touching your skin, why laser is usually the wrong first step, and what a plan that holds looks like in South Florida.
A calm, clinician-written guide to tirzepatide: how it differs from semaglutide, what the trial numbers really say, the side effects worth knowing, what the Metabolic Reset Panel checks before your first dose, and where compounded versions stand right now.
What GHK-Cu actually is, what the research supports versus what's still thin, why injectable GHK-Cu isn't legally compoundable right now, and how it fits into a lab-guided longevity plan.
Why the scale moves during menopause even when your habits haven't changed, what visceral fat, cortisol, insulin resistance, and under-eating have to do with it, and why labs (not a diet plan) are the real starting point.
If you've been told you're "too young" for menopause symptoms, here's what a real workup should include and how to find a specialist who actually runs labs before treating you.
The real cost, timeline, and side effects of semaglutide in Miami, plus what changed with compounding rules in 2026 and why GLP-1 alone isn't a plan.
Looking for a HydraFacial in Miami? Here's what the Hydrofacial by Zemits Dermaluxx actually is, how it compares to the Allergan brand, and what to expect.
What sermorelin actually is, how it differs from HGH and tesamorelin, and how to get it safely in Miami Lakes instead of from an anonymous online reseller.
The 12 most common perimenopause symptoms, how to tell it apart from stress, and why labs, not a checklist, confirm what stage you're actually in.
The FDA advisory panel voted yes on several peptides this week. Here is what the vote actually does, what it does not, and how we think about peptide therapy at Hydra Prime.